Tekcapital announced further expansion of MicroSalt’s distribution network with the addition of Longs Drugs and 70 stores across Hawaii.
Longs Drugs is owned by $91bn market cap CVS Health.
“We are very excited about the placement of our SaltMe Low Sodium Crisps with the Longs Drug Chain. Excess sodium consumption is one of the leading contributors to hypertension and heart disease. Placements like this are the best way to provide consumers with great tasting, healthy products with less sodium,” said Rick Guiney, CEO of MicroSalt®.
MicroSalt slashes the amount of sodium in foods and can help improve the health of those suffering from cardiovascular diseases. An estimated 31% of adults worldwide suffer from high blood pressure and other cardiovascular diseases.
Growth in MicroSalt’s distribution channels comes days after the announcement that MicroSalt’s IPO will be rescheduled with a new date expected in mid-November.
